⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18032727 | 0.92 | TUBB4A (0.56) | — | |
| SCHEMBL18032725 | 0.88 | DPP4 (0.49) | — | |
| SCHEMBL14667872 | 0.86 | DPP4 (0.51) | — | |
| SCHEMBL9050215 | 0.81 | ALDH1A1 (0.47) | — | |
| SCHEMBL14649126 | 0.77 | — | — | |
| SCHEMBL27492784 | 0.77 | ALDH1A1 (0.37) | — | |
| SCHEMBL11065521 | 0.77 | ALDH1A1 (0.46) | — | |
| SCHEMBL16894427 | 0.77 | ALDH1A3 (0.42) | — | |
| SCHEMBL16901839 | 0.77 | ALDH1A1 (0.46) | — | |
| SCHEMBL1763234 | 0.76 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239979-A | Self-assembled monolayer material, and preparation method and application thereof | 天合光能股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4698170-A1 | GLYCINAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF SALMONELLOSIS | Eberhard-Karls-Universität Tübingen (DE) | 2026-02-25 | — | — | EP | disclosed |
| CN-120118124-A | Nitrogen-rich DOPO-based flame retardant, synthesis and application thereof | 常州大学 | 2025-06-10 | — | — | CN | disclosed |
| US-20250145601-A1 | NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS | SATYA THERAPEUTICS, INC. | 2025-05-08 | — | — | US | disclosed |
| CN-119320366-A | Substituted naphthalene methyl oxadiazole-aniline compound and application thereof | 中国医学科学院药物研究所 | 2025-01-17 | — | — | CN | disclosed |
| EP-4482831-A1 | NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS | Satya Therapeutics, Inc. (US) | 2025-01-01 | — | — | EP | disclosed |
| WO-2024218333-A1 | GLYCINAMIDE DERIVATIVES FOR USE IN THE TREATMENT OF SALMONELLOSIS | EBERHARD KARLS UNIVERSITÄT TÜBINGEN MEDIZINISCHE FAKULTÄT (DE) | 2024-10-24 | — | — | WO | disclosed |
| CN-118696034-A | Novel bicyclic compounds as RAD51 inhibitors | 萨提亚疗法股份有限公司 | 2024-09-24 | — | — | CN | disclosed |
| US-12037531-B2 | Photoresponsive high-molecular weight material, adhesive, toner, and image forming method | Konica Minolta, Inc. (JP) | 2024-07-16 | — | — | US | disclosed |
| CN-118239979-A | Self-assembled monolayer material, and preparation method and application thereof | 天合光能股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-0540673-A4 | — | — | 1994-04-27 | — | — | EP | disclosed |
| EP-0540673-A1 | ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY. | ABBOTT LAB (US) | 1993-05-12 | — | — | EP | disclosed |
| US-5100911-A | Antiarrhythmic agents | EBEWE ARZNEIMITTEL GESELLSCHAFT M.B.H. (AT) | 1992-03-31 | — | — | US | disclosed |
| WO-1992001682-A1 | ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY | ABBOTT LABORATORIES (US) | 1992-02-06 | — | — | WO | disclosed |
| US-4760147-A | Isopropyl 1,4-dihydro-2,6-dimethyl-4-(2,3-dichlorophenyl)-3-(1,3,4-oxadiazol-2 -yl)pyridine-5-carboxylate | CASSELLA AKTIENGESELLSCHAFT (DE) | 1988-07-26 | — | — | US | disclosed |
| US-4681891-A | Dihydro-2,6-dimethyl pyridines, formulations and method of use for treating angina pectoris, high blood pressure or disturbances of cerebral or peripheral blood flow | CASSELLA AKTIENGESELLSCHAFT (DE) | 1987-07-21 | — | — | US | disclosed |
| EP-0183091-A2 | 1,4-Dihydropyridines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1986-06-04 | — | — | EP | disclosed |
| EP-0172509-A2 | Process for the preparation of optically active, substituted 1,4-dihydropyridines and their use as medicaments | CASSELLA Aktiengesellschaft (DE) | 1986-02-26 | — | — | EP | disclosed |
| US-4558058-A | HYPOTENSIVE AGENTS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1985-12-10 | — | — | US | disclosed |
| EP-0116708-A1 | Substituted 1,4-dihydropyridines, method for their preparation and their use as pharmaceuticals | CASSELLA Aktiengesellschaft (DE) | 1984-08-29 | — | — | EP | disclosed |